Loading...
![Thumbnail Image](assets/images/Collection.png)
Theses
Browse
3 results
Search Results
ThesisItem Open Access Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducine oestrus in bitches(Department of Animal Reproduction, Gynaecology and Obstetrics, College of Veterinary and Animal Sciences, Mannuthy, 2008) Ajitkumar, G; KAU; Sreekumaran, TDetailed survey on breeding, feeding and management of 1721 dogs belonging to 817 owners was conducted in different parts of Kerala State. Among the dogs surveyed, 518 (30.10%) were male and 1203 (69.90%) were female. Breed-wise details of dogs maintained by individual owners revealed German shepherd dog (20.74%) as the most popular breed of dog followed by Labrador retriever (18.13%), Dachshund (11.39%), Rottweiler (9.12%) and Spitz (5.52%). The percentage of local non-descript dogs was found to be 14.64 only. The prevalence, nature and magnitude of anoestrus among the female dogs were evaluated based on breeding details. Haematological, hormonal, mineral and cholesterol profile of anoestrous bitches were estimated. Data on breeding revealed that 92.93 per cent of bitches were allowed to breed and the remaining 7.07 per cent were kept as virgin throughout their lifetime. The age at first breeding in majority of the bitches (57.85%) was between 1 to 2 years with an average of 16.30 months. The average number of oestrus periods and the number of breeding per year were 2.14 ± 0.24 and 1.47 ± 0.32 respectively. The average duration of proestrual bleeding was found to be 10.87 ± 1.24 days. Most of the bitches (51.97 %) were bred twice in one oestrus and the period of acceptance varied from 4 to 22 days with an average of 8.94 ± 2.18 days. The incidence of failure of conception, abortion, stillbirth and pseudopregnancy were 18.87, 5.72, 15.56 and 13.69 per cent respectively. The neonatal problems encountered in 13.88 per cent of bitches included agalactia / hypogalactia / mammitis (5.29%), cannibalism (2.65%), puppy fading syndrome (2.09%), puerperal tetany (1.98%) and rejection of young one by dam / poor mothering ability (1.87%). Among the bitches surveyed, 134 (11.14%) were identified as in the stage of anoestrus, 65.67 per cent in primary and 34.33 per cent in secondary anoestrus and the average age was 22.68 and 34.34 months respectively. The average duration of secondary anoestrus was 11.71 months. Analysis of breed-wise prevalence revealed that it was high in breeds such as Dachshund (18.18%), Labrador retriever (16.74%), Great Dane (16.67%), Dalmatian (15.38%) and Doberman pinscher (14.00%) and was lowest (2.44%) among local non-descript bitches. Data on body condition revealed that 42 per cent of the anoestrous bitches were with the ideal body score of five, 46 per cent with body score more than five (obese) and 12 per cent with body score less than five (lean). Analysis of haematological profile of anoestrous bitches revealed normochromic normocytic anaemia. The mean serum progesterone, prolactin and thyroxine levels in anoestrous bitches were of 0.57 ± 0.03 ng/ml, 0.75 ± 0.05 ng/ml and 1.80 ± 0.06 µg/dl respectively. The mean serum calcium and phosphorus levels in anoestrous bitches were 8.94 ± 0.24 and 3.48 ± 0.12 mg per cent respectively. The mean serum iron, copper, cobalt, zinc, manganese and cholesterol levels were found to be within the normal range. Oestrus induction trials were carried out in forty anoestrous bitches and the data obtained were compared with that of control bitches. Out of 10 animals treated in each group, five (50%) in Group I (bromocriptine @ 50 μg/kg. body weight), nine (90%) in Group II (cabergoline @ 5 μg/kg. body weight), eight (80%) in Group III (thyroxine @10 μg/kg. body weight) and seven (70%) in Group IV (thyroxine @ 5 μg/kg. body weight) evinced proestrual bleeding. The mean treatment onset to proestrus in Groups I, II, III and IV was 28 ± 3.39, 13.44 ± 3.12, 24.50 ± 3.18 and 33 ± 2.21 days respectively. The average duration of proestrus in the treatment groups was 9.80 ± 0.86, 10.11 ± 0.68, 11.25 ± 0.88 and 10.71 ± 0.68 days respectively as against 9.70 ± 0.42 days in the control group. The average duration of oestrus in the four treatment groups and the control group was 7.60 ± 0.24, 8 ± 0.29, 8.5 ± 0.63, 7.85 ± 0.46 and 8 ± 0.39 days respectively. Fifty per cent of the animals treated with bromocriptine and 10 per cent of the animals treated with cabergoline exhibited nausea and vomiting as side effects, whereas none of the animals treated with thyroxine exhibited side effects. The mean serum progesterone and prolactin levels during anoestrus, on the first day of proestrus and on the day of first breeding did not differ significantly within and between the treatment groups and the control group. The mean serum thyroxine level during anoestrus and on the first day of proestrus did not differ significantly within and between the treatment and the control groups, whereas on the day of first breeding the mean thyroxine level recorded statistically significant difference between the treatment and control groups, the lowest being 1.56 ± 0.18 μg/dl in Group I and the highest being 2.10 ± 0.13 μg/dl in Group IV. Animals treated with levothyroxine (Group III & IV) exhibited a slight increase in the mean level of serum thyroxine on the first day of bleeding as well as on the day of first breeding, but the values were found to be within the normal limits. The haemoglobin level and total erythrocyte count were found to be increased on the first day of proestrus and on the day of first breeding in animals of Group III and IV. The mean serum phosphorus level on the first day of proestrus and on the day of first breeding in the treatment groups were found to continue at low levels as in the anoestrous stage. The mean serum copper level on the first day of proestrus exhibited statistically significant difference between the treatment and control groups. The mean serum level of calcium, iron, cobalt, zinc and manganese during anoestrus, on the first day of proestrus and on the day of first breeding did not reveal statistically significant difference between groups. The overall conception rate in the treatment groups were 40, 70, 50 and 40 per cent respectively as against 70 per cent in the control group. The average gestation length and litter size did not differ significantly between the treatment and control groups.ThesisItem Open Access Superovulation, Sychronisation of oestrus and embryo transfer in crossbred cows(Department of Animal Reproduction, College of Veterinary and Animal Sciences, Mannuthy, 1992) Suresan Nair, S P; KAU; Neelakanta Iyer, C PThe object of the present investigation was to ascertain the influence of varying doses of FSH and PGF2₻on various parameters of superovulation and embryo collections, with the ultimate aim of fixing the optimum dose of FSH and PGF2 ₻ required for successful superovulation in crossbred cows. Detailed investigation was made in a herd of 32 crossbred cows belonging to the University Livestock Farm, attached to the College of Veterinary and Animal Sciences, Mannuthy, during the period from April 1989 to December, 1991. The animals were randomly divided into 6 groups based on 3 doses of FSH and 2 doses of PGF2 ₻ administered. It was observed that 20 mg of FSH, with 25 mg of PGF2 induced satisfactory superovulation response and 20 mg of FSH with 15 mg of PGF2 ₻ resulted in better embryo quality. Further increase in the dose did not show any improvement in the responses. Right ovary showed more response than the left. Day 11 was found to be ideal for starting superovulation treatment, and day 6 for embryo collection, though statistically no significant influence was noticed by day of collection on superovulation response. Parity and age of donors had no influence on superovulation. Rainy and summer months were found to be better seasons for superovulation treatment than winter. Shorter duration (24 hr) of oestrum was noticed in more number of animals. 20 mg of FSH and 25 mg of PGF2 ₻ (group 3) yielded better cervical dilatation and flushing efficiency. Level of progesterone increased following superovulation treatment and declined 3 days before oestrum and reached the lowest level on day of oestrum. Pregnancy rate achieved was 33.3 per cent, but calving percentage was nil.ThesisItem Open Access Ovarian response to gonadotrophin releasing hormone in non-cyclic goats(Department of Animal Reproduction, College of Veterinary and Animal Sciences, Mannuthy, 1998) Aravinda Ghosh, K N; KAU; Mathai, EThe study was conducted to evaluate the effect of Gonadotropic Releasing Hormone (GnRH) on ovarian activity and its usefulness in restoring normal oestrous cycle in adult non-cyclic goats. A total of 60 healthy Malabari, Malabari x Saanen and Malabari x Alpine does aged one to four years, with a record of one or more kiddings and 45 days post partum belonging to Goat Farm of Kerala Agricultural University, Mannuthy were closely observed for a period of 60 days for the occurrence of oestrus and serum samples were collected at fortnightly intervals for the estimation of macro and micro minerals. Serum progesterone profile in eight cyclic and sixteen non-cyclic does, selected at random, were estimated by Radioimmunoassay using a coat-A-count progesterone kit. Out of eight non-cyclic does treated with potent GnRH anologue (Buserelin) three responded to single dose and one responded to a second dose. The oestrus was exhibited at a mean of 87.000 ± 9.950 h after the administration of GnRH analogue. The mean length of oestrous cycle and duration of oestrus in cyclic does were 20.313 ± 1.553 days and 37.500 ± 7.263 hrs while in GnRH responded does were 12.750 ± 0.830 days and 18.000 ± 4.240 hrs, respectively. The mean serum phosphorus level was found significantly higher in GnRH responded does (5.375 ± 0.205 mg per cent) as compared to cyclic does (4.800 ± 0.260 mg per cent) and non-cyclic does (4.770 ± 0.280 mg per cent). There was significantly higher serum copper level in GnRH responded (1.123 ± 0.089 ppm) and in cyclic does (1.160 ± 0.170 ppm) as compared to non-cyclic controls (0.830 ± 0.110 ppm) . The serum zinc level was significantly higher in non-cyclic (1.510 ± 0.430 ppm) as compared to cyclic (1.180 ± 0.120 ppm) and GnRH responded does (1.155 ± 0.091 ppm). There was no significant difference in the serum calcium, cobalt and manganese level between the three groups. The mean serum progesterone in cyclic does for the two consecutive cycles was 0.304 ± 0.087, 1.294 ± 0.382, 2.531 ± 0.758, 3.619 ± 0.794, 2.456 ± 0.430 and 0.871 ± 0.246 ng/ml and in GnRH responded does was 0.158 ± 0.026, 0.800 ± 0.177, 1.475 ± 0.334, 0.675 ± 0.236, 0.280 ± 0.030 and 0.120 ± 0.021 ng/ml on day one, four, six, ten, 14 and 18 of cycle, respectively. The overall mean serum progesterone during induced cycle in GnRH responded does was 0.535 ± 0.139 ng/ml which was significantly lower as compared to cyclic does (1.848 ± 0.339 ng/ml) but significantly higher as compared to untreated non-cyclic does (0.190 ± 0.106 ng/ml), Detailed biometry studies of pituitary ovary, uterus and cervix of GnRH responded does showed non-significant increase in the size and weight as compared to untreated non-cyclic does. The mean number and size of follicles were found significantly higher in GnRH responded as compared to non-cyclic does. The mean tissue ACP, ALP and LDH in the pituitary, ovary and uterus of GnRH responded does showed non significant increase as compared to untreated non-cyclic does. The mean LDH level in both ovaries together was significantly higher in GnRH responded does as compared to non-cyclic does. The present study confirms that GnRH administration in non-cyclic does has reactivated the ovary by increased follicular growth, maturation and corpus luteum formation. However, the length of induced oestrous cycle, duration and intensity of oestrus was significantly less in GnRH responded does